BRAIDWELL LP
Q1 2025 Form 13-F
STAMFORD, CONNECTICUT
CIK 0001920938
· CRD 316988
· SEC-registered investment adviser
$2.8B Reported Value Total
BRAIDWELL LP reports 12 total accounts under management (AUM). There are 12 discretionary accounts valued at $5,228,467,000, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
13 funds
· $3.6B gross asset value
Hedge Fund: $3.6B · Private Equity Fund: $0
Source: Form ADV filed 2026-09-22
Reported value
$2.8B
Quarter over quarter
-9.3%
Holdings
52
Top-10 concentration
40.1%
Key People
Form ADV owners & control persons
Alexander Thomas Karnal
MANAGING MEMBER
Brian James Kreiter
MANAGING MEMBER
Ken C Joseph
CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2025 13F record
Q1 2025 13F filing summary
| Period of report | March 31, 2025 |
|---|---|
| Filed | May 15, 2025 |
| Form | 13F-HR |
| Reported value | $2.8B |
| Positions | 52 |
| Change in reported value | -15.7% |
| New positions | 13 |
| Exited positions | 22 |
| Position turnover | 47.3% |
| Top-10 concentration | 40.1% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
83 | $2.7B |
|
Q1 2026 13F
Filed May 15, 2026
|
82 | $3.0B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
68 | $3.1B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
64 | $3.4B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
45 | $2.9B |
|
Q1 2025 13F
Filed May 15, 2025
|
52 | $2.8B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
59 | $3.4B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
65 | $3.5B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
58 | $3.2B |
|
Q1 2024 13F
Filed May 15, 2024
|
51 | $3.1B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
47 | $2.7B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
60 | $3.2B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
58 | $3.1B |
|
Q1 2023 13F
Filed May 15, 2023
|
57 | $3.0B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
63 | $3.0B |
Top 20 holdings · Q1 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | GH 1.25 02/15/31 GUARDANT HEALTH INC | $227.4M | 7.99% |
| 2 | NVCR 0 11/01/25 NOVOCURE LTD | $136.6M | 4.8% |
| 3 | NBIX NEUROCRINE BIOSCIENCES INC | $131.8M | 4.63% |
| 4 | LEGN LEGEND BIOTECH CORP | $101.0M | 3.55% |
| 5 | RGEN 1 12/15/28 REPLIGEN CORP | $95.8M | 3.37% |
| 6 | ARGX ARGENX SE | $95.2M | 3.35% |
| 7 | XENE XENON PHARMACEUTICALS INC | $90.9M | 3.2% |
| 8 | IRTC 1.5 09/01/29 IRHYTHM TECHNOLOGIES INC | $89.7M | 3.15% |
| 9 | NEO 0.25 01/15/28 NEOGENOMICS INC | $87.9M | 3.09% |
| 10 | ALGN ALIGN TECHNOLOGY INC | $84.3M | 2.96% |
| 11 | IRWD 1.5 06/15/26 IRONWOOD PHARMACEUTICALS INC | $82.5M | 2.9% |
| 12 | CGON CG ONCOLOGY INC | $80.4M | 2.83% |
| 13 | KRYS KRYSTAL BIOTECH INC | $72.3M | 2.54% |
| 14 | BBIO 2.5 03/15/27 BRIDGEBIO PHARMA INC | $72.0M | 2.53% |
| 15 | TMO THERMO FISHER SCIENTIFIC INC | $63.6M | 2.23% |
| 16 | DHR DANAHER CORPORATION | $63.4M | 2.23% |
| 17 | GKOS GLAUKOS CORP | $61.5M | 2.16% |
| 18 | NUVL NUVALENT INC | $59.6M | 2.1% |
| 19 | IRTC IRHYTHM TECHNOLOGIES INC | $58.2M | 2.05% |
| 20 | APGE APOGEE THERAPEUTICS INC | $57.5M | 2.02% |
Values as reported on the Q1 2025 Form 13F. Every position is in the holdings table below.